Sectors

LFWD
Lifeward Ltd.
8.02
1 x 7.17
1 x 18.00
bid
ask
+
0.33
4.29%
04:50 PM
timesize
Ytd15.90%
1y-0.74%
7.30
day range
8.02
4.14
52 week range
10.98
Open7.66Prev Close7.69Low7.30High8.02Mkt Cap22.57M
Vol29.71KAvg Vol9.16KEPS-18.33P/EN/AForward P/E-1.59
Beta2.08Short Ratio3.79Inst. Own21.64%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg7.09200-d Avg7.281yr Est9.50

LFWD News

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
gurufocus.com
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
globenewswire.com
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilita

Veteran physician , medical affairs and clinical research leader brings 30 years of rehabilitation m

Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
seekingalpha.com
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript

Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates

Lifeward (LFWD) came out with a quarterly loss of $6.7 per share versus the Zacks Consensus Estimate

Lifeward Q1 2026 Earnings Call Transcript
benzinga.com
Lifeward Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Lifeward Reports First Quarter 2026 Financial Results
globenewswire.com
Lifeward Reports First Quarter 2026 Financial Results

Oramed  strategic transaction successfully closed and $10 million financing received Oratech acquisi

Earnings Scheduled For May 15, 2026
benzinga.com
Earnings Scheduled For May 15, 2026

Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
globenewswire.com
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFW

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
globenewswire.com
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive

Global data since 2013 show just 3% lifetime fracture prevalence, declining to 0.3% over the past si

Lifeward (NASDAQ:LFWD) Trading Up 2.5%  – Should You Buy?
defenseworld.net
Lifeward (NASDAQ:LFWD) Trading Up 2.5% – Should You Buy?

Lifeward Ltd. (NASDAQ: LFWD - Get Free Report) shares were up 2.5% on Thursday. The stock traded as

benzinga.com
Lifeward Closes The Strategic Partnership Agreement With Oramed Pharmaceuticals

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innova

Lifeward Successfully Closes on Strategic Partnership with Oramed
globenewswire.com
Lifeward Successfully Closes on Strategic Partnership with Oramed

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd.

benzinga.com
HC Wainwright & Co. Maintains Buy on Lifeward, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Lifeward (NASDAQ:LFWD) with a Bu

Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
seekingalpha.com
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript

benzinga.com
Lifeward Q4 Adj. EPS $(2.85) Misses $(1.08) Estimate, Sales $5.081M Miss $7.861M Estimate

Lifeward (NASDAQ:LFWD) reported quarterly losses of $(2.85) per share which missed the analyst conse

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Advancing t ransformation into a d iversified b iomedical i nnovation c ompany with a c lear p ath t

Earnings Scheduled For March 18, 2026
benzinga.com
Earnings Scheduled For March 18, 2026

benzinga.com
Lifeward Shareholders Approve Issuance Of Ordinary Shares Over Previously Announced Collaboration De

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innov

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
globenewswire.com
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Divers

Position s Lifeward as a diversified biomedical innovation company with clear path to profitability

benzinga.com
Lifeward Regains Nasdaq Compliance

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innov

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd.

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
globenewswire.com
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasd

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
globenewswire.com
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Person

Clinic  d ays offered at Shirley Ryan AbilityLab, the #1 ranked rehabilitation hospital for 35 conse

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
globenewswire.com
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function

IP and technology acquisition is expected to be highly accretive and to advance Lifeward's position

Lifeward Announces Reverse Share Split
globenewswire.com
Lifeward Announces Reverse Share Split

Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTec

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
globenewswire.com
Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of t

Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Lifeward To Issue $10M In Senior Secured Convertible Notes In A Private Placement, Of Which Oramed T

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and

benzinga.com
UPDATE: Lifeward To Acquire Oramed's POD Technology And Secure Up To $47M Strategic Investment As Or

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
globenewswire.com
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotec

Oramed and Lifeward Announce Strategic Transaction
prnewswire.com
Oramed and Lifeward Announce Strategic Transaction

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Pos

benzinga.com
Lifeward Appoints Bob Marshall Board Chairman, Effective Jan. 1, Succeeding Joseph Turk

Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innov

benzinga.com
Lifeward Expands Patient Access To ReWalk Personal Exoskeleton Through New International Distributio

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal E

benzinga.com
HC Wainwright & Co. Maintains Buy on Lifeward, Lowers Price Target to $4.5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Lifeward (NASDAQ:LFWD) with a Bu

benzinga.com
Lifeward Gets First Prior Authorization From UnitedHealthcare Medicare Advantage Plan For ReWalk 7 P

Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in inno

benzinga.com
Lifeward Affirms FY2025 Sales Guidance of $24.000M-$26.000M vs $25.101M Est

Lifeward (NASDAQ:LFWD) affirms FY2025 sales outlook from $24.000 million-$26.000 million to $24.000

benzinga.com
Lifeward Q3 Adj. EPS $(0.19) Beats $(0.21) Estimate, Sales $6.195M Miss $6.311M Estimate

Lifeward (NASDAQ:LFWD) reported quarterly losses of $(0.19) per share which beat the analyst consens

Earnings Scheduled For November 14, 2025
benzinga.com
Earnings Scheduled For November 14, 2025

A Look Ahead: Lifeward's Earnings Forecast
benzinga.com
A Look Ahead: Lifeward's Earnings Forecast

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Lifeward Receives First Payment From Commercial Medicare Advantage Plan For ReWalk 7 Personal Exoske

Medicare Advantage claim processed in less than thirty daysAdditional progress with traditional Medi

benzinga.com
Lifeward Receives CE Mark For ReWalk 7 Exoskeleton; Expands Commercial Sales In Europe

Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innov

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
The US Defense Health Agency Is Awarding A Sole Source Contract To Lifeward For Surgical And Medical

https://sam.gov/opp/09d936af89b2496392773ea6302bda5c/view

benzinga.com
Lifeward Lowers FY2025 Sales Guidance from $28.000M-$30.000M to $24.000M-$26.000M vs $28.191M Est

Lifeward (NASDAQ:LFWD) lowers FY2025 sales outlook from $28.000 million-$30.000 million to $24.000 m

benzinga.com
Rewalk Robotics Q2 Adj. EPS $(0.31) Misses $(0.30) Estimate, Sales $5.724M Miss $6.694M Estimate

Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.31) per share which missed the analys

benzinga.com
Earnings Scheduled For August 14, 2025

Crude Oil Rises Sharply; Torrid Holdings Shares Plunge
benzinga.com
Crude Oil Rises Sharply; Torrid Holdings Shares Plunge

US Stocks Mixed; General Mills Shares Fall After Q4 Results
benzinga.com
US Stocks Mixed; General Mills Shares Fall After Q4 Results